Company intelligence / Profile preview

MedAustron

Wiener Neustadt, Lower Austria, Austriamedaustron.at ↗

Ownership: Private
Employees: ~180
Development stage: Commercial

Overview

MedAustron has been clinically operational since December 2016. It initially offered proton therapy and expanded to include carbon ion therapy in mid-to-late 2019. The center treats a growing number of patients annually across an expanding range of cancer indications. It operates as one of only six centers worldwide offering both proton and carbon ion therapies.

Therapeutic areas: Oncology
Modalities: Device (Particle accelerator for ion beam therapy)Radiopharmaceutical (Proton and carbon ion therapy)Non-pharmacological therapy (Radiation/ion beam therapy)
Industry: Academic Hospital/University/Research

Partnerships

CERNTERA FoundationItalian National Institute for Nuclear Physics (INFN)CNAO FoundationPaul Scherrer InstituteKarl Landsteiner University of Health Sciences

Beyond the preview

Go deeper on MedAustron.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedAustron.

Explore the full profile